FDA Drug Recalls

Recalls / Class I

Class ID-0429-2024

Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.

Product

Treprostinil Injection, 20 mg/20 mL (1 mg/mL), For Subcutaneous or Intravenous Infusion Only, 20 mL Multiple-Dose Vial, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-206-01

Affected lot / code info
Lot#: 57014; Exp, 04/30/2024

Why it was recalled

Presence of Particulate Matter.

Recalling firm

Firm
Par Sterile Products LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
870 Parkdale Rd, N/A, Rochester, Michigan 48307-1740

Distribution

Quantity
466 vials
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2024-03-04
FDA classified
2024-03-28
Posted by FDA
2024-04-03
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0429-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.